This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Apostolia Tsimberidou, MD, PHD
M.D. Anderson Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- China Medical University Hospital
Taichung, Taiwan
- National Cheng Kung University Hospital
Tainan, Taiwan
- Taipei Veterans General Hospital
Taipei, Taiwan
- Scripps Clinic Torrey Pines
La Jolla, California, United States
- Usc/norris Comprehensive Cancer Center
Los Angeles, California, United States
- Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- West Cancer Center and Research Institute
Germantown, Tennessee, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 May 2018
- Primary completion
- 7 Apr 2022
- Completion
- 7 Apr 2022
- Last update posted
- 22 Feb 2024
- Registered enrollment
- 54
- Registry id
- NCT03573544
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.